Although the active ingredient is neither teratogenic nor mutagenic and has not shown any negative effect on the reproductive function in animals, Fluifort should not be administered during pregnancy. As no data are available concerning the excretion of carbocysteine monohydrate lysine salt in breast milk, use of the medicinal product during lactation is contraindicated.